Angiotensin type I receptor blockade in conjunction with enhanced Akt activation restores coronary collateral growth in the metabolic syndrome

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 300, Issue 5, 2011, Pages

  Jadhav, Rashmi ^a   Dodd, Tracy ^a   Smith, Erika ^a   Bailey, Erin ^b   Delucia, Angelo L ^b   Russell, James C ^c   Madison, Rowan ^d   Potter, Barry ^d   Walsh, Kenneth ^e   Jo, Hanjoong ^f   Rocic, Petra ^a  

^a UNIVERSITY OF SOUTH ALABAMA   (United States)

^b Northeastern Ohio Medical University   (United States)

^c UNIVERSITY OF ALBERTA   (Canada)

^d LOUISIANA STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^f Emory University   (United States)

Author keywords

Coronary artery occlusion; Transient

Indexed keywords

ADENOVIRUS VECTOR; ANGIOTENSIN 1 RECEPTOR ANTAGONIST; CANDESARTAN; PROTEIN KINASE B;

ADENOVIRUS; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY COLLATERAL CIRCULATION; CORONARY COLLATERAL GROWTH; DRUG EFFICACY; GENE ACTIVATION; GENE EXPRESSION; HEART INFARCTION; HEART MUSCLE; HEART MUSCLE BLOOD FLOW; HEART MUSCLE REVASCULARIZATION; ISCHEMIA; MALE; METABOLIC SYNDROME X; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; RAT; REPETITIVE ISCHEMIA; SIGNAL TRANSDUCTION; VIRAL GENE DELIVERY SYSTEM;

ADENOVIRIDAE; ANGIOTENSIN II TYPE 2 RECEPTOR BLOCKERS; ANIMALS; BENZIMIDAZOLES; COLLATERAL CIRCULATION; CORONARY VESSELS; DISEASE MODELS, ANIMAL; MALE; METABOLIC SYNDROME X; MYOCARDIUM; PROTO-ONCOGENE PROTEINS C-AKT; RATS; RATS, INBRED WKY; RECEPTOR, ANGIOTENSIN, TYPE 1; REGIONAL BLOOD FLOW; TETRAZOLES;

EID: 79955748837     PISSN: 03636135     EISSN: 15221539     Source Type: Journal    
DOI: 10.1152/ajpheart.00282.2010     Document Type: Article

References (37)

1. Ackah E, Yu J, Zoellner S, Iwakiri Y, Skurk C, Shibata R, Ouchi N, Easton R, Galasso G, Birnbaum M, Walsh K, Sessa W. Akt1/PKBalpha is critical for ischemic and VEGF-mediated angiogenesis. J Clin Invest 115: 2119-2127, 2005.
2. Boo YC, Sorescu G, Boyd N, Shiojima I, Walsh K, Du J, HJ. Shear stress stimulates phosphorylation of endothelial nitric-oxide synthase at Ser1179 by Akt-independent mechanisms: role of protein kinase A. J Biol Chem 277: 3388-3396, 2002.
3. Bussolati B, Dunk C, Grohman M, Kontos CD, Mason J, Ahmed A. Vascular endothelial growth factor receptor-1 modulates vascular endothelial growth factor-mediated angiogenesis via nitric oxide. Am J Pathol 159: 993-1008, 2001.
4. Cai WJ, Koltai S, Kocsis E, Scholz D, Kostin S, Luo X, Schaper W, Schaper J. Remodeling of the adventitia during coronary arteriogenesis. Am J Physiol Heart Circ Physiol 284: H31-H40, 2003.
5. Chen JS, Wang Q, Fu XH, Huang XH, Chen XL, Cao LQ, Chen LZ, Tan HX, Li W, Bi J, Zhang LJ. Involvement of PI3K/PTEN/AKT/ mTOR pathway in invasion and metastasis in hepatocellular carcinoma: association with MMP-9. Hepatol Res 39: 177-186, 2009.
6. Dimmeler S, Fleming I, Fisslthaler B, Hermann C, Busse R, Zeiher AM. Activation of nitric oxide synthase in endothelial cells by Aktdependent phosphorylation. Nature 399: 601-605, 1999.
7. Dulak J, Józkowicz A. Regulation of vascular endothelial growth factor synthesis by nitric oxide: facts and controversies. Antioxid Redox Signal 5: 123-132, 2003.
8. Hayashi K, Takahashi M, Kimura K, Nishida W, Saga H, Sobue K. Changes in the balance of phosphoinositide 3-kinase/protein kinase B (Akt) and the mitogen-activated protein kinases (ERK/p38MAPK) determine a phenotype of visceral and vascular smooth muscle cells. J Cell Biol 145: 727-740, 1999.
9. Hughes GC, Annex BH. Angiogenic therapy for coronary artery and peripheral arterial disease. Expert Rev Cardiovasc Ther 3: 521-535, 2005.
10. Iglarz M, Silvestre JS, Duriez M, Henrion D, Lévy BI. Chronic blockade of endothelin receptors improves ischemia-induced angiogenesis in rat hindlimbs through activation of vascular endothelial growth factor- no pathway. Arterioscler Thromb Vasc Biol 21: 1598-1603, 2001.
11. Kawahara S, Umemoto S, Tanaka M, Umeji K, Matsuda S, Kubo M, Matsuzaki M. Up-regulation of Akt and eNOS induces vascular smooth muscle cell differentiation in hypertension in vivo. J Cardiovasc Pharmacol 45: 367-374, 2005.
12. Koerselman J, van der Graaf Y, de Jaegere P, Grobbee D. Coronary collaterals: an important and underexposed aspect of coronary artery disease. Circulation 107: 2507-2511, 2003.
13. Lee SU, Wykrzykowska JJ, Laham RJ. Angiogenesis: bench to bedside, have we learned anything? Toxicol Pathol 34: 3-10, 2006.
14. Liao JK. Fine-tuning the angiogenic response to vascular endothelial growth factor. Circ Res 103: 229-230, 2008.
15. Liu P, Sun M, Sader S. Matrix metalloproteinases in cardiovascular disease. Can J Cardiol, Suppl B: 25B-30B, 2006.
16. Madeddu P, Kraenkel N, Barcelos L, Siragusa M, Campagnolo P, Oikawa A, Caporali A, Herman A, Azzolino O, Barberis L, Perino A, Damilano F, Emanueli C, Hirsch E. Phosphoinositide 3-kinase gama gene knockout impairs postischemic neovascularization and endothelial progenitor cell function. Arterioscler Thromb Vasc Biol 28: 68-76, 2008.
17. Maulik N, Das D. Potentiation of angiogenic response by ischemic and hypoxic preconditioning of the heart. Cell Mol Med 6: 13-24, 2002.
18. Miller SJ, Norton LE, Murphy MP, Dalsing MC, Unthank JL. The role of the renin-angiotensin system and oxidative stress in spontaneously hypertensive rat mesenteric collateral growth impairment. Am J Physiol Heart Circ Physiol 292: H2523-H2531, 2007.
19. Miyauchi H, Minamino T, Tateno K, Kunieda T, Toko H, Komuro I. Akt negatively regulates the in vitro lifespan of human endothelial cells via a p53/p21-dependent pathway. EMBO J 23: 212-220, 2004.
20. O'Neill BT, Abel ED. Akt1 in the cardiovascular system: friend or foe? J Clin Invest 115: 2059-2064, 2005.
21. Reed R, Potter B, Smith E, Jadhav R, Villalta P, Jo H, Rocic P. Redox-sensitive Akt and Src regulate coronary collateral growth in metabolic syndrome. Am J Physiol Heart Circ Physiol 296: H1811-H1821, 2009.
22. Reed R, Kolz C, Potter B, Rocic P. The mechanistic basis for the disparate effects of angiotensin II on coronary collateral growth. Arterioscler Thromb Vasc Biol 28: 61-67, 2008.
23. Risinger GM Jr, Hunt TS, Updike DL, Bullen EC, Howard EW. Matrix metalloproteinase-2 expression by vascular smooth muscle cells is mediated by both stimulatory and inhibitory signals in response to growth factors. J Biol Chem 281: 25915-25925, 2006.
24. Rocic P, Kolz C, Reed R, Potter B, Chilian W. Optimal reactive oxygen species concentration and p38 MAP kinase are required for coronary collateral growth. Am J Physiol Heart Circ Physiol 292: H2729-H2736, 2007.
25. Ruggero D, Sonenberg N. The Akt of translational control. Oncogene 24: 7426-7434, 2005.
26. Russell JC, Graham SE, Amy RM, Dolphin PJ. Inhibition of myocardial lesions in the JCR:LA-corpulent rat by captopril. J Cardiovasc Pharmacol 31: 971-977, 1998.
27. Russell JC, Kelly SE, Proctor SD. The JCR:LA-cp rat: an animal model of the metabolic syndrome exhibiting micro- and macro-vascular disease. In: Animal Models of Diabetes, edited by Shafrir E. Baton Rouge, LA: CRC, 2007.
28. Russell JC, Kelly SE, Vine DF, Proctor SD. Irbesartan-mediated reduction of renal and cardiac damage in insulin resistant JCR:LA-cp rats. Br J Pharmacol 158: 1588-1596, 2009.
29. Sasaki K, Murohara T, Ikeda H, Sugaya T, Shimada T, Shintani S, Imaizumi T. Evidence for the importance of angiotensin II type 1 receptor in ischemia-induced angiogenesis. J Clin Invest 109: 603-611, 2002.
30. Schaper W. Collateral circulation: past and present. Basic Res Cardiol 104: 5-21, 2009.
31. Shiojima I, Sato K, Izumiya Y, Schiokofer S, Ito M, Liao R, Colucci W, Walsh K. Disruption of coordinated cardiac hypertrophy and angiogenesis contributes to the transition to heart failure. J Clin Invest 115: 2108-2118, 2005.
32. Shiojima I, Walsh K. Regulation of cardiac growth and coronary angiogenesis by the Akt/PKB signaling pathway. Genes Dev 20: 3347-3365, 2006.
33. Silvestre JS, Tamarat R, Senbonmatsu T, Icchiki T, Ebrahimian T, Iglarz M, Besnard S, Duriez M, Inagami T, Lévy BI. Antiangiogenic effect of angiotensin II type 2 receptor in ischemia-induced angiogenesis in mouse hindlimb. Circ Res 90: 1072-1079, 2002.
34. Toblli JE, Cao G, DeRosa G, Di Gennaro F, Forcada P. Angiotensinconverting enzyme inhibition and angiogenesis in myocardium of obese Zucker rats. Am J Hypertens 17: 172-180, 2004.
35. Toyota E, Warltier D, Brock T, Ritman E, Kolz C, O'Malley P, Rocic P, Focardi M, Chilian W. Vascular endothelial growth factor is required for coronary collateral growth in the rat. Circulation 112: 2108-2113, 2005.
36. Vander Haar E, Lee SI, Bandhakavi S, Griffin TJ, Kim DH. Insulin signaling to mTOR mediated by the Akt/PKB substrate PRAS40. Nat Cell Biol 9: 316-323, 2007.
37. Walther T, Menrad A, Orzechowski HD, Siemeister G, Paul M, Schirner M. Differential regulation of in vivo angiogenesis by angiotensin II receptors. FASEB J 17: 2061-2067, 2003.